Product Categories
| Country: | China |
|---|---|
| Tel: | 020-020-81960175-877 |
| Mobile: | +8618933936954 |
| E-mail: | tianwen.zhan@cato-chem.com |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Sodium Fusidate EP Impurity G | C31H46O6 | 4680-37-9 | Details |
| Sodium Fusidate EP Impurity H | C31H46O6 | 16711-91-4 | Details |
| Sodium Fusidate EP Impurity I | C29H46O5 | 5951-83-7 | Details |
| Gabapentin EP Impurity A | C9H15NO | 64744-50-9 | Details |
| Gabapentin EP Impurity B | C9H13NO2 | 133481-09-1 | Details |
| Gabapentin EP Impurity D | C18H29NO3 | 1076198-17-8 | Details |
| Gabapentin EP Impurity G | C10H19NO2 | 1500558-49-5 | Details |
| Gadobutrol EP Impurity C (Gadoteridol USP Related Compound B) | C14H22GdN4O6 | 112188-16-6 | Details |
| Gatifloxacin Related Compound D(3-Desmethyl Gatifloxacin) | C18H20FN3O4 | 112811-57-1 | Details |
| Ganciclovir EP Impurity I | C15H21N5O6 | 86357-20-2 | Details |
| Ganciclovir EP Impurity H | C9H13N5O4 | 84222-50-4 | Details |
| Ganciclovir EP Impurity F | C5H5N5O | 73-40-5 | Details |
| Ganciclovir EP Impurity E | C9H13N5O4 | 86357-09-7 | Details |
| Ganciclovir EP Impurity D | C10H15N5O5 | 1346598-14-8 | Details |
| Gatifloxacin Impurity 2 | C16H18FN3O4 | 172426-86-7 | Details |
| Gatifloxacin Impurity 14 | C20H24FN3O4 | 114213-69-3 | Details |
| Ganciclovir EP Impurity J | C18H25N5O7 | 177216-32-9 | Details |
| Ganciclovir Divalinate Impurity | C19H31N7O6 | 130914-71-5 | Details |
| Gentamicin | C60H123N15O21 | 1403-66-3 | Details |
| Gentamicin EP Impurity E(Hydrobromate) | C6H15BrN2O3 | 84107-26-6 | Details |
| Gentamicin Impurity 8 | C20H41N5O7 | 59751-72-3 | Details |
| Chlorobromo Isocyanuric Acid | C3HBrClN3O3 | 89325-49-5 | Details |
| Ganciclovir EP Impurity B | C12H17N5O5 | 194159-18-7 | Details |
| Ganciclovir EP Impurity C | C9H12ClN5O3 | 108436-36-8 | Details |
| Tritracine tetraacetic acid | C16H28N4O8 | 60239-18-1 | Details |
| Galantamine EP Impurity F (ent-Galantamine) | C17H21NO3 | 60384-53-4 | Details |
| Galantamine EP Impurity B (epi-Galantamine) | C17H21NO3 | 1668-85-5 | Details |
| Galantamine EP Impurity E HBr | C16H19NO3 | 41303-74-6 | Details |
| Galantamine Impurity 6 | C16H19NO3 | 60755-80-8 | Details |
| Galantamine EP Impurity D (Anhydro Galantamine) | C17H19NO2 | 664995-65-7 | Details |
| Galantamine EP Impurity C (Dihydro Galantamine) | C17H23NO3 | 21133-52-8 | Details |
| Galantamine EP Impurity A (Galantaminone) | C17H19NO3 | 510-77-0 | Details |
| Ganciclovir EP Impurity A | C9H10ClN5O2 | 1797982-93-4 | Details |
| Gatifloxacin Impurity 4 | C18H19F2N3O3 | 103460-89-5 | Details |
| Gatifloxacin Impurity 3 | C18H20FN3O4 | 616205-76-6 | Details |
| Gemcitabine EP Impurity C | C9H10F2N2O5 | 114248-23-6 | Details |
| Gefitinib Impurity 18 | C9H11NO4 | 50413-44-0 | Details |
| Gefitinib Impurity 11 | C6H5ClFN | 367-21-5 | Details |
| Gefitinib | C22H24ClFN4O3 | 184475-35-2 | Details |
| Gatifloxacin USP RC E | C19H22FN3O4 | 1029364-65-5 | Details |
| Gatifloxacin Impurity 7 | C17H20FN3O4 | 172426-87-8 | Details |
| Glimepiride impurity C | C18H23N3O6S | 119018-30-3 | Details |
| Glipizide EP Impurity A | C14H16N4O3S | 33288-71-0 | Details |
| Glipizide EP Impurity J | C17H20N4O5S | 1076198-09-8 | Details |
| Glimepiride EP Impurity B | C16H21N3O4S | 119018-29-0 | Details |
| Glipizide EP Impurity G | C16H18N4O5S | 33288-74-3 | Details |
| Glipizide EP Impurity F | C11H16N2O4S | 192118-08-4 | Details |
| Glipizide EP Impurity E | C21H27N5O4S | 66375-96-0 | Details |
| Glipizide EP Impurity D | C14H16N4O3S | 1346600-54-1 | Details |
| Glipizide EP Impurity C | C18H27N3O5S | 13554-93-3 | Details |
| Glipizide Impurity 14 | C8H12N2O2S | 35303-76-5 | Details |
| Gliclazide EP Impurity A | C7H9NO2S | 70-55-3 | Details |
| Gliclazide EP Impurity B | C7H12N2O | 54786-86-6 | Details |
| Gliclazide EP Impurity C | C10H13NO4S | 5577-13-9 | Details |
| Gliclazide BP Impurity D | C15H20N2O3S | 1136426-19-1 | Details |
| Gliclazide EP Impurity E | C15H19N3O3S | 1808087-53-7 | Details |
| Glutathione EP Impurity D | C8H14N2O5S | 636-58-8 | Details |
| L-alpha-Glycerophosphorylcholine | C8H20NO6P | 28319-77-9 | Details |
| Glyceryl Trinitrate Solution EP Impurity B | C3H7NO5 | 624-43-1 | Details |
| Glyceryl Trinitrate Solution EP Impurity C | C3H7NO5 | 620-12-2 | Details |
| Glyceryl Trinitrate Solution EP Impurity D | C3H6N2O7 | 621-65-8 | Details |
| Glyceryl Trinitrate Solution EP Impurity E | C3H6N2O7 | 623-87-0 | Details |
| Glycopyrrolate USP Related Compound L | C14H18O3 | 19833-96-6 | Details |
| Glycopyrrolate USP Related Compound C | C13H16O3 | 427-49-6 | Details |
| Glycopyrrolate Impurity 5 | C13H16O2 | 3900-93-4 | Details |
| Glycopyrrolate Impurity 9 | C19H27BrClNO3 | 1404453-68-4 | Details |
| Glycopyrronium Bromide EP Impurity N Bromide (and enantiomer) | C19H28BrNO3 | 58493-54-2 | Details |
| 3,4-Dideoxyglucosone-3-ene | C6H8O4 | 252006-38-5 | Details |
| Glucosamine Sulfate Impurity 5 | C16H28N2O11 | 35061-50-8 | Details |
| Glucosamine Sulfate EP Impurity A | C8H15NO6 | 7512-17-6 | Details |
| Glipizide EP Impurity I | C22H34N4O4S | 10079-35-3 | Details |
| Glipizide EP Impurity H | C15H23N3O3S | 10080-05-4 | Details |
| Glycopyrrolate USP Related Compound B | C18H25NO3 | 13118-11-1 | Details |
| Glycopyrrolate USP Related Compound B HCl | 13118-10-0 | Details |
| Glycopyrrolate Impurity 1 | C6H14BrNO | 51052-74-5 | Details |
| Glycopyrronium Bromide EP Impurity H | C9H8O3 | 15206-55-0 | Details |
| Glycopyrrolate Bromide | C19H28BrNO3- | 596-51-0 | Details |
| Guaifenesin Impurity 6 | C7H8O2 | 90-05-1 | Details |
| Granisetron EP Impurity I | C18H14N4O3 | 1363173-34-5 | Details |
| Guaifenesin EP Impurity B | C10H14O4 | 14007-09-1 | Details |
| Guaifenesin EP Impurity C | C20H26O7 | 1797132-23-0 | Details |
| Guaifenesin EP Impurity D | C17H20O5 | 16929-60-5 | Details |
| Granisetron EP Impurity B | C17 H22 N4 O | 107007-95-4 | Details |
| Granisetron EP Impurity A | C18H24N4O | 127472-42-8 | Details |
| Granisetron Impurity 11(Mixture of Z and E Isomers) | C10H11N3O3 | 123704-98-3 | Details |
| Granisetron EP Impurity F | C18H24N4O | 1364914-39-5 | Details |
| Granisetron EP Impurity E | C9H18N2 | 76272-56-5 | Details |
| Granisetron EP Impurity C | C17H22N4O | 160177-67-3 | Details |
| Goserelin Impurity 41 TFA Salt | C34H38N8O9 | 52434-75-0 | Details |
| Guaifenesin Impurity 5 | C11H12O5 | 2049-21-0 | Details |
| Guanfacine Hydrochloride Impurity 2 | C8H7Cl2NO | 78433-88-2 | Details |
| Haloperidol EP Impurity A | C21H24FNO2 | 3109-12-4 | Details |
| Haloperidol EP Impurity B | C21H23ClFNO2 | 1391052-53-1 | Details |
| Haloperidol EP Impurity C | C23H27ClFNO2 | 1391052-87-1 | Details |
| Haloperidol EP Impurity D | C32H36Cl2N2O3 | 67987-08-0 | Details |
| Haloperidol EP Impurity F | C27H27ClFNO2 | 1391052-67-7 | Details |
| Haloperidol EP Impurity E | C27H27ClFNO2 | 1391054-69-5 | Details |
| Adenosine Impurity 13 | C5H10O4S | 49540-14-9 | Details |
| Hydrochlorothiazide Impurity 15 | C7H8ClN3O4S2 | 1190006-03-1 | Details |
| Hydrochlorothiazide EP Impurity B | C6H8ClN3O4S2 | 121-30-2 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 | ||||